coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Central Worthing Practices PCN, Worthing · Health Inequalities Profile

    PCN U13952 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    42,188

    Registered population

    60.6% aged 18–64

    20.8%

    Aged 65+

    ICB 21.9% · England 17.9%

    9.2%

    Ethnic minority (non-White)

    4.2% Asian · England 9.6%

    4.2%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~1,738

    Core20 residents (est.)

    Resident basis; registered basis ~1,898 · see page 3

    7,348

    Hypertension register

    +5.31% in 3 yrs · England +5.60%

    546

    SMI register

    34.1% of Worthing's

    783

    COPD register

    Reviews +6.24% in 3 yrs

    Forecast to 2030

    8,285

    Hypertension patients, 2030

    +937 on today

    70.8%

    QRISK ≥20% on statins, 2030

    +3.94pp over 3 yrs

    6.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -4.9%
    Heart failure reviews fell over three years.

    Reviews fell 4.9% from 2023 to 2025 (England +8.7%), leaving current coverage at 75.5% against 78.5% in England, which may reflect recall gaps.

    -5.8 pp
    Smoking cessation offers dropped against England.

    Offers fell 5.8 pp from 2023 to 2025 (England +0.1 pp) to 92.0% (England 94.2%), with Broadwater Medical Centre at 75.6%.

    87.0%
    Mental health blood pressure checks exceed comparators.

    Annual blood pressure checks on the severe mental illness register reached 87.0% (England 83.4%, ICB 81.3%) after rising 10.5 pp (England +4.4 pp).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older residents comprise 20.8% of the list alongside 71 catchment care homes

    Central Worthing Practices PCN registers 42,188 patients across three practices. Patients aged 65+ represent 20.8% (8,756 patients), below Worthing (22.1%) and NHS Sussex ICB (21.9%), but above England (17.9%). The 0–17 cohort comprises 18.6% (7,846 patients; Worthing 17.4%, ICB 17.7%, England 19.6%), and ages 18–64 account for 60.6% (25,586 patients). Usual residents are 90.8% White (Worthing 91.4%, ICB 91.0%, England 81.1%), leaving a 9.2% ethnic minority share; ethnicity reflects Census area estimates rather than GP records. Projected population growth to 2030 is 1.4% (Worthing 1.9%, ICB 2.1%, England 2.3%), though projection methodology remains unverified.

    Age profile

    0–1718.6%
    18–6460.6%
    65+20.8%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White90.8%
    Asian4.2%
    Mixed2.7%
    Black1.3%
    Other1.1%

    Older people · falls rows are Worthing local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Worthing LA)2,4902,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.1%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.6%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Worthing LA)1,4809819552024/25
    Falls deaths, all ages, per 100,000 (Worthing LA)15.814.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Overall deprivation is low but Core20 patients concentrate in two practices

    The PCN Core20 cohort is 4.2%, below Worthing (4.4%), NHS Sussex Integrated Care Board (9.2%) and England (21.0%), with an average IMD decile of 6.5 (England 5.5). Weighted practice share models at 4.5%, showing a minor reconciliation difference against the PCN rate. Across an 8.9 pp practice range, Victoria Road Surgery has an 8.9% Core20 share (1,251 estimated patients) and Broadwater Medical Centre has 5.6% (647 estimated patients), while St. Lawrence Surgery records 0.0%. This distribution indicates proactive reviews could be prioritised where deprived cohorts concentrate.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Victoria Road8.9% · 1,251 patients
    Broadwater5.6% · 647 patients
    St. Lawrence0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    546

    SMI register

    1.29% recorded prevalence

    310

    Learning disability register

    0.73% recorded prevalence

    71

    Care homes, 1,829 beds

    In the PCN catchment

    9.0%

    Provide unpaid care

    Worthing, Census 2021

    Recorded severe mental illness prevalence is 1.3% (546 patients; Worthing 1.3%, NHS Sussex ICB 1.1%, England 1.0%), and learning disability prevalence is 0.7% (310 patients; Worthing 0.7%, ICB 0.6%, England 0.6%). The PCN catchment encompasses 71 care homes containing 1,829 beds. Crude register prevalence slightly above England reflects recorded diagnoses rather than unmet need, and catchment bed capacity does not establish registered care-home resident counts.

    Severe mental illness: physical health checks

    SMI checks reached 87.0% for blood pressure (England 83.4%) and 84.5% for BMI (England 82.1%). Smoking cessation offers were 92.0% (England 94.2%), with Broadwater Medical Centre recording 75.6%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,348

    Hypertension register

    +5.31%

    Register growth, 3 yrs

    Worthing +3.32% · England +5.60%

    +3.67pp

    BP control, under 80

    ≤140/90 · +2.44pp aged 80+

    +937

    More patients by 2030

    Forecast 8,285 (19.21%)

    Hypertension case-finding and control

    Hypertension recorded QOF prevalence is 17.3%, below Worthing (17.4%), but above NHS Sussex Integrated Care Board (16.3%) and England (15.2%).

    Lipids and statins

    For patients with QRISK at or above 20%, 62.1% receive lipid-lowering therapy, below England (63.6%) but above Worthing (57.8%) and NHS Sussex Integrated Care Board (60.0%). Statin coverage for diabetes primary prevention is 72.3%, below England (73.2%) and matching NHS Sussex Integrated Care Board (72.3%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202685,725£2.00£2.42£1.86£171,450
    Cardiovascular (all), 2025106,508£3.52£3.32£3.33£374,908

    In 2026, the PCN prescribed 85,725 lipid-regulating drug items at £2.00 each (£171,450 spend), compared to £1.86 in England, £2.24 in Worthing, and £2.42 across NHS Sussex Integrated Care Board, spending £12,002 more than at England's unit cost across 85,725 items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +5.39%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.37%

    Asthma prevalence, PCN 3-yr % change

    Asthma recorded prevalence is 8.0% (England 6.6%) and COPD prevalence is 1.9% (England 1.9%). Annual reviews reached 70.1% for asthma (England 65.7%) and 80.7% for COPD (England 76.4%), though an estimated 955 asthma patients lacked a recorded review. Second-hand smoke status recording for asthma patients aged 6–19 was 72.4% (England 78.8%), with Broadwater Medical Centre at 52.9%. Prescribing for asthma management was 1,432 items per 1,000 population aged 5–19 (England 1,488).

    Cancer register and children's immunisation

    Cancer prevalence is 4.9% (England 3.8%). In childhood immunisations, age-5 uptake exceeds England (MMR dose 2 at 92.2% vs 82.8%; 4-in-1 booster at 90.0% vs 80.9%) but misses the 95% target. A 43.5 pp practice spread in QOF vaccination achievement and a 7.7 pp MMR dose difference at St. Lawrence Surgery indicate uneven delivery, meaning preschool booster call-recall requires proactive coordination.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.3%

    England 91.0%

    6-in-1 complete primary course at 24 months93.2%

    England 92.2%

    MMR dose 1 at 24 months95.5%

    England 88.3%

    MMR dose 2 at age 592.2%

    England 82.8%

    4-in-1 pre-school booster at age 590.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    Across NHS Sussex ICB in 2022, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, above England (55.3%) and up +5.0 pp since 2013, but 16.5 pp below the 75.0% national ambition (about 1,360 extra early-stage cases needed). Known-stage completeness was 64.3% (8,209 of 12,766; England 67.0%); staging reflects system pathways, not PCN performance. At PCN level, recorded cancer prevalence is 4.9% (England 3.8%), rising +11.4% over three years (England +9.0%). PCN screening coverage is 77.9% for breast (England 69.9%) and 71.7% for cervical (England 66.8%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day standard, 19.8 pp below the 85.0% standard and trailing East Sussex Healthcare NHS Trust (67.0%), Surrey and Sussex Healthcare NHS Trust (70.0%), NHS Surrey and Sussex Integrated Care Board (71.5%), and England (71.2%). Its 31-day treatment performance was 76.8% (standard 96.0%; ICB 90.4%), and 28-day faster diagnosis was 74.0% (England 79.3%). Across provider diagnostics, 12.9% waited 6+ weeks, with 39.3% for colonoscopy and 45.4% for flexi sigmoidoscopy (England 30.8% and 32.1%); this reflects provider waiting times, not PCN performance.

    Pathways within standard (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2077.7479.2979.32
    31-day treatment (96%)76.7998.1996.2090.4592.50
    62-day referral to treatment (85%)65.2067.0469.9771.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareEngland
    MRI5.626.4827.5321.40
    CT8.570.4818.499.92
    Echocardiography0.3921.9443.7828.48
    Colonoscopy39.350.7415.1130.83
    Gastroscopy20.020.3121.0629.02
    All 15 DM01 tests12.955.2728.5023.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). Provisional experimental community data for June 2026 recorded 115,485 care activities and 78,050 care contacts for West Sussex residents, alongside 316,320 activities and 309,615 contacts across NHS Surrey and Sussex Integrated Care Board. Contacts with adults aged 65 and over accounted for 72.7% of West Sussex resident contacts (56,740 of 78,050); this reflects wider borough activity rather than PCN-level service use.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Vaccination achievement and Core20 share diverge across the three practices

    In 2025/26, clinical QOF achievement was 100.0% at St. Lawrence Surgery, Victoria Road Surgery, and Broadwater Medical Centre (England 97.1%). Vaccination achievement spanned 43.5 pp, from 53.5% at Broadwater Medical Centre to 97.0% at Victoria Road Surgery (England 55.2%). Overall QOF achievement reached 94.7% at Broadwater Medical Centre and 99.7% at Victoria Road Surgery (England 92.5%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    St. Lawrence1260.057.6%83.7%91.5%
    Victoria Road918.940.0%68.6%87.2%
    Broadwater945.641.1%62.3%68.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWorthingAssetPCNWorthing
    Care homes (catchment)71 (1,829 beds)n/aSchools (catchment)43n/a
    Children's centres57Places of worship3748
    Libraries35Homelessness support (VCS)0no data
    Day centres (VCS)11Carers support groups (VCS)11
    Primary schools (LA maintained)1013Primary academies88
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Smoking cessation and asthma smoke recording

    Smoking cessation offers are 92.0% (England 94.2%), falling 5.8 pp over 2023 to 2025 (England +0.1 pp), with Broadwater Medical Centre at 75.6%. For discussion: audit clinical templates and run targeted recall for smoking cessation offers and child asthma smoke exposure recording, starting at Broadwater Medical Centre. Low cost, quick to run.

    Option 2

    Heart failure reviews and register check

    Heart failure reviews are 75.5% (England 78.5%) after falling 4.9% (England +8.7%). The 474-patient register (1.1%) has a modelled gap of -11 to +37 against England (1.1%) and Worthing (1.2%). For discussion: run structured recall for overdue annual heart failure functional reviews and audit register coding in Core20 practices. Moderate effort to run.

    Option 3

    CVD lipid therapy and stroke coding

    Lipid therapy for QRISK >= 20% is 62.1% (England 63.6%). Recorded stroke prevalence is 2.0% (858 patients; Worthing 2.4%, England 1.9%), a modelled gap of -61 to +156. For discussion: run pharmacist-led recall for patients with QRISK >= 20% or diabetes off statins, and audit hospital discharge stroke coding. Moderate effort to run.

    Evidence base: the stroke/TIA register is the cohort for AF anticoagulation and blood-pressure control (pre-stroke prevention) as well as hyperacute care; practices well below expected prevalence are the case-finding list, and the pre-stroke prevention gap concentrates in deprived practices.

    Policy anchor: Core20PLUS5 (CVD); NHS CVD ambitions to 2029.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Care home MDT capacity (p2)Count of care home beds in PCN catchmentFit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework: revenue finance and contracting guidance 2026PCN
    Targeted Core20 clinical review outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Targeted smoking cessation outreach (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Preschool booster recall review (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening equity audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Smoking cessation and asthma smoke recording (p12)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)—PCN & Practice
    Option 2 · Heart failure reviews and register check (p12)Heart failure register · Heart Failure: QOF prevalence · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs)—PCN
    Option 3 · CVD lipid therapy and stroke coding (p12)Stroke register · Stroke: QOF prevalence · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT · SSNAPPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15